BACKGROUND: Allogeneic stem cell transplantation (allo-SCT) is an efficacious treatment for hematologic malignancies but can ...

The average blood cancer patient loses 15–24% of their cardiovascular fitness during the allogeneic stem cell transplantation ...

Updated guidelines on allogeneic hematopoietic stem cell transplantation for myelofibrosis examine spleen-related ...

My son won’t need monthly hospital trips anymore.""I’m happy to be better and grateful to the doctors," said Vuong, touching ...

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage allogeneic cell therapy and genetic medicines company advancing ...

Graft-versus-host disease prophylaxis using posttransplant cyclophosphamide remains a valid option for patients with ...

Analysis By Type, By Stem Cell Source, By Application, By End User, By Region Size and Trends Forecast up to 2029" report has ...

At the center of this fight is how the FDA regulates a possible "functional cure" for Type 1 diabetes and determines who gets ...

The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced that ...